NIH-funded research R01 grant

How cholesterol affects brain problems from cirrhosis

Official title: Role of cholesterol in the pathogenesis of hepatic encephalopathy

Funded at University of Texas at Austin · NIH-11182574 · Data updated 2026-11-12

This research looks at whether cholesterol builds up in the brain and changes neurosteroids, contributing to hepatic encephalopathy in adults with liver cirrhosis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin
NIH-funded
Lab location1 site (Austin, United States)
Project startSeptember 5, 2024
Project endAugust 31, 2028
Funding year2025
Award (this year)$558,484
NIH project number5R01DK135995-02
Project IDNIH-11182574 on NIH RePORTER

Who could benefit from this research

Could help

Adults with liver cirrhosis who have had episodes of hepatic encephalopathy or are at risk for it.

Less likely to help

People without liver disease or whose cognitive symptoms have other causes may not benefit from cholesterol-targeted approaches.

What this research studies

Researchers will use models that mimic liver cirrhosis to measure free and membrane-bound cholesterol in the brain and to track changes in neurosteroid production. They will map the pathways that normally control brain cholesterol and test how those pathways are disrupted during hepatic encephalopathy. Experiments will link cholesterol and neurosteroid changes to neurological signs similar to what patients experience. The team will use those findings to suggest whether targeting cholesterol or neurosteroid pathways could prevent or reverse brain dysfunction in cirrhosis.

Why it matters

Potential benefit: If successful, this work could point to new treatments that prevent or reduce the thinking, memory, and attention problems caused by hepatic encephalopathy.

How similar studies have gone: Previous work found cholesterol buildup linked to hepatic encephalopathy after acute liver failure, but applying that finding to cirrhosis-related encephalopathy is a new step.

Where this research is happening

  • University of Texas at Austin
    Austin, United States
    Active

Researchers

  • Principal investigator: Demorrow, Sharon — University of Texas at Austin
  • Study coordinator: Demorrow, Sharon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.